Cited by 376Cancer-related Molecular PathwaysUbiquitin and proteasome pathwaysTGF-β signaling in diseases

Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase

Honda, R, Yasuda, H·2000·Oncogene

Abstract

We previously showed that oncoprotein MDM2 has ubiquitin ligase activity toward tumor suppressor p53. In that paper, we showed very weak homology in the carboxyl terminal portion between MDM2 and E6AP (HECT domain). We mutated the cysteine residue (C464) corresponding to the residue essential for the ubiquitin ligase activity of E6AP and this mutation diminished the ligase activity of MDM2. The cysteine residue described above is also one of the cysteine residues that form the RING finger domain of MDM2. We tried to find out whether the diminishing of the activity by the mutation is attributable to the disruption of the RING finger domain or not. When the ring finger domain of MDM2 was deleted, the truncation mutant did not have the ubiquitin ligase activity. When we mutated the seven cysteine residues of RING finger domain of MDM2 in the carboxyl terminus, the disruption of each residue in the RING finger completely diminished the ubiquitin ligase activity of MDM2 toward MDM2 itself and toward tumor suppressor p53. These data indicate that the RING finger domain in MDM2 is essential for its ubiquitin ligase activity toward p53 and itself.

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1203464

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mdm2 is a RING-type E3 ubiquitin ligase that ubiquitylates itself and p53, leading to their proteasomal degradation.

    “Mdm2 is a RING-type E3 ubiquitin ligase (Honda et al., 1997;Fang et al., 2000;Honda and Yasuda, 2000), which directs the ubiquitylation of itself and p53.”

    From Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms (2001) · cites this paper as Honda and Yasuda, 2000

The citation lists haven’t been fetched yet

References 19 · Cited by 376

Authors
Honda, R., & Yasuda, H.
Affiliations
Tokyo University of Pharmacy and Life Sciences (JP)
Venue
Oncogene
Published
2000-03-09
Volume
19
Issue
11
Pages
1473-1476
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2058015944
Cited by
376
References
19
Citations by year
2026: 3 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 11 · 2021: 11 · 2020: 3 · 2019: 9 · 2018: 5 · 2017: 10 · 2016: 16 · 2015: 12 · 2014: 14 · 2013: 12 · 2012: 18
FWCI
12.18
Type
journal article
Language
en
Open access
closed
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
MDM2, p53, ubiquitin ligase activity, RING domain, UBE3A, HECT domain, cysteine residues, ubiquitination, tumor suppressor degradation
MeSH terms
Amino Acid Sequence, Animals, Ligases, Molecular Sequence Data, Nuclear Proteins, Proto-Oncogene Proteins, Ubiquitins, Zinc Fingers, Protein Structure, Tertiary, Catalytic Domain, Ubiquitin-Protein Ligases, Mice, Proto-Oncogene Proteins c-mdm2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review